Skip to main content

and
  1. Article

    Open Access

    Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study

    This phase I, dose-finding study determined the maximum tolerated dose (MTD), safety, and pharmacokinetics of sunitinib plus gemcitabine in patients with advanced solid tumours.

    M D Michaelson, A X Zhu, D P Ryan, D F McDermott, G I Shapiro in British Journal of Cancer (2013)

  2. No Access

    Article

    A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells

    Neoplastic events are marked by uncontrolled cell proliferation. One major focus of cancer research has been to identify treatments that reduce or inhibit cell growth. Over the years, various compounds, both n...

    KM Eck, L Yuan, L Duffy, PT Ram, S Ayettey, I Chen, CS Cohn in British Journal of Cancer (1998)